Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor
- 31 January 1994
- journal article
- research article
- Published by Elsevier in Molecular Brain Research
- Vol. 21 (1-2) , 171-175
- https://doi.org/10.1016/0169-328x(94)90391-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The sequence of 5′ flanking DNA from the rat preprotachykinin gene; analysis of putative transcription factor binding sitesBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1993
- Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldose reductase inhibitionNeuroscience Letters, 1992
- Identification and cDNA sequence of δ‐preprotachykinin, a fourth splicing variant of the rat substance P precursorFEBS Letters, 1990
- Monoclonal antibodies distinguishing α and β forms of calcitonin gene-related peptideJournal of Immunological Methods, 1990
- Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathyJournal of Neuroscience Research, 1990
- Neuropeptide expression in cultures of adult sensory neurons: Modulation of substance P and calcitonin gene-related peptide levels by nerve growth factorNeuroscience, 1989
- Nerve growth factor regulates expression of neuropeptide genes in adult sensory neuronsNature, 1989
- Neuron‐Enriched cultures of adult rat dorsal root ganglia: Establishment, characterization, survival, and neuropeptide expression in response to trophic factorsJournal of Neuroscience Research, 1987
- [23] Methods for the identification of neuropeptide processing products: Somatostatin and the tachykininsPublished by Elsevier ,1986
- Retrograde Axonal Transport of Transmitter Enzymes, Fucose-Labeled Protein, and Nerve Growth Factor in Streptozotocin-Diabetic RatsDiabetes, 1981